Poseida Therapeutics, Inc.
(NASDAQ : PSTX)

( )
PSTX After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -3.76%167.520.0%$1572.37m
NVAXNovavax, Inc. -2.13%90.3678.2%$615.65m
AMGNAmgen, Inc. -1.04%228.901.4%$505.63m
BIIBBiogen, Inc. -2.12%225.911.8%$493.88m
GILDGilead Sciences, Inc. -1.82%67.811.0%$457.06m
BNTXBioNTech SE -3.17%156.530.0%$428.66m
ILMNIllumina, Inc. -1.02%380.443.3%$383.57m
REGNRegeneron Pharmaceuticals, Inc. -0.60%614.382.7%$380.02m
VRTXVertex Pharmaceuticals, Inc. -0.97%228.611.9%$333.31m
SNSSSunesis Pharmaceuticals, Inc. -4.17%2.760.7%$192.93m
EXASEXACT Sciences Corp. -0.13%76.0317.9%$166.25m
ARNAArena Pharmaceuticals, Inc. -0.55%91.0113.7%$134.19m
INCYIncyte Corp. -0.03%74.762.4%$128.59m
ALNYAlnylam Pharmaceuticals, Inc. -0.22%138.318.2%$127.21m
BBIOBridgeBio Pharma, Inc. -2.05%11.460.0%$102.72m

Company Profile

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of non-viral gene engineering technologies for the treatment of hematological malignancies and solid tumors. Its products pipeline include autologous and allogeneic chimeric antigen receptor T cell, or CAR-T. The company was founded by Eric M. Ostertag in December 2014 and is headquartered in San Diego, CA.